Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China (mainland).
Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital with Nanjing Medical University, Nanjing, Jiangsu, China (mainland).
Med Sci Monit. 2020 Jan 31;26:e918382. doi: 10.12659/MSM.918382.
BACKGROUND The coatomer protein complex subunit beta 2 (COPB2) gene is upregulated and promotes cell proliferation in some cancer cells. This study aimed to investigate the role of microRNA (miRNA) targeting by COPB2 gene expression in human lung adenocarcinoma cell lines, including NCI-H1975 cells. MATERIAL AND METHODS COPB2 expression in normal human bronchial epithelial cells and lung adenocarcinoma cells was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot. NCI-H1975 human lung adenocarcinoma cells were transfected with short-interfering COPB2 (siCOPB2). Cell apoptosis and cell proliferation were evaluated by flow cytometry and Cell Counting Kit-8 (CCK-8) assays, respectively. The transwell assay evaluated cell migration. Targeting of miR-335-3p by COPB2 was predicted using TargetScan 7.2 and verified using a dual-luciferase reporter assay in NCI-H1975 cells. MiR-335-3p mimics were transfected into NCI-H1975 cells. The further functional analysis included detection of protein expression for cyclin D1, tissue inhibitor matrix metalloproteinase-1 (TIMP-1), matrix metallopeptidase 9 (MMP9), Bcl-2, and Bax, to verify the role of miR-335-3p targeting by COPB2 in lung adenocarcinoma cells. RESULTS COPB2 was upregulated in lung adenocarcinoma cells and was a direct target of miR-335-3p mimics. COPB2 knockdown promoted cell apoptosis, inhibited cell migration and proliferation in NCI-H1975 cells. The effects of COPB2 knockdown on NCI-H1975 cells were increased by miR-335-3p mimics, which also further reduced the expression levels of cyclin D1, MMP9, and Bcl-2 and further increased TIMP-1 and Bax by siCOPB2. CONCLUSIONS This study showed that COPB2 was the functional target of miR-335-3p in NCI-H1975 human adenocarcinoma cells.
背景:衣被蛋白复合物亚基β 2(COPB2)基因在一些癌细胞中上调并促进细胞增殖。本研究旨在探讨 COPB2 基因表达通过 microRNA(miRNA)靶向在人肺腺癌细胞系中的作用,包括 NCI-H1975 细胞。
材料与方法:通过定量逆转录-聚合酶链反应(qRT-PCR)和 Western blot 测量正常人类支气管上皮细胞和肺腺癌细胞中的 COPB2 表达。用短发夹 RNA(siCOPB2)转染 NCI-H1975 人肺腺癌细胞。通过流式细胞术和细胞计数试剂盒-8(CCK-8)测定分别评估细胞凋亡和细胞增殖。Transwell 测定评估细胞迁移。使用 TargetScan 7.2 预测 COPB2 对 miR-335-3p 的靶向作用,并在 NCI-H1975 细胞中使用双荧光素酶报告基因测定进行验证。转染 miR-335-3p 模拟物进入 NCI-H1975 细胞。进一步的功能分析包括检测细胞周期蛋白 D1、组织抑制剂基质金属蛋白酶-1(TIMP-1)、基质金属肽酶 9(MMP9)、Bcl-2 和 Bax 的蛋白表达,以验证 COPB2 对肺腺癌细胞中 miR-335-3p 靶向作用的作用。
结果:COPB2 在肺腺癌细胞中上调,是 miR-335-3p 模拟物的直接靶标。COPB2 敲低促进 NCI-H1975 细胞的细胞凋亡,抑制细胞迁移和增殖。COPB2 敲低对 NCI-H1975 细胞的影响通过 miR-335-3p 模拟物增加,这进一步降低了细胞周期蛋白 D1、MMP9 和 Bcl-2 的表达水平,并进一步增加了 siCOPB2 的 TIMP-1 和 Bax。
结论:本研究表明,COPB2 是 NCI-H1975 人腺癌细胞中 miR-335-3p 的功能靶标。
Biosci Biotechnol Biochem. 2020-10
Biomed Pharmacother. 2018-4-24
Exp Mol Pathol. 2019-4-11
Technol Cancer Res Treat. 2019
Technol Cancer Res Treat. 2018-1-1
Acta Biochim Biophys Sin (Shanghai). 2023-10-25
Animals (Basel). 2022-6-13
Cancers (Basel). 2022-4-18
Clin Transl Oncol. 2021-11
Cancers (Basel). 2019-3-11
Cancer Genomics Proteomics. 2019
Cancers (Basel). 2019-2-26
Cancers (Basel). 2019-2-23
CA Cancer J Clin. 2019-1-8